Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Olson

Showing results (851-860 of 1,043) with videos related to

Pageof 105
Sort By:
Plos One|March 26, 2013
Leucine and protein metabolism in obese Zucker ratsPengxiang She, Kristine C Olson, Yoshihiro Kadota, et al.
Urologic Oncology|October 9, 2025
An opportunity to save? SBRT is less costly than IMRT for intermediate-risk prostate cancerVanessa N Peña, Shan Wu, Oluwaseun Orikogbo, et al.
BMC Medical Research Methodology|March 15, 2020
Incorporating sampling weights into robust estimation of Cox proportional hazards regression model, with illustration in the Multi-Ethnic Study of AtherosclerosisColleen M Sitlani, Thomas Lumley, Barbara McKnight, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 1994
Human biodistribution and dosimetry of the SPECT benzodiazepine receptor radioligand iodine-123-iomazenilH M Dey, J P Seibyl, J B Stubbs, et al.
Journal for Immunotherapy of Cancer|March 14, 2024
Cancer-oocyte SAS1B protein is expressed at the cell surface of multiple solid tumors and targeted with antibody-drug conjugatesArabinda Mandal, Jagathpala Shetty, Christine A Tran, et al.
The Journal of Experimental Medicine|April 28, 2023
Secretory MPP3 reinforce myeloid differentiation trajectory and amplify myeloid cell productionYoon-A Kang, Hyojung Paik, Si Yi Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2004
Administration of CI-1033, an irreversible pan-erbB tyrosine kinase inhibitor, is feasible on a 7-day on, 7-day off schedule: a phase I pharmacokinetic and food effect studyEmiliano Calvo, Anthony W Tolcher, Lisa A Hammond, et al.
Journal of Virology|June 16, 2005
Virus isolates during acute and chronic human immunodeficiency virus type 1 infection show distinct patterns of sensitivity to entry inhibitorsPeter Rusert, Herbert Kuster, Beda Joos, et al.
Plos Pathogens|November 7, 2007
HIV-1 gp120 mannoses induce immunosuppressive responses from dendritic cellsMeimei Shan, Per Johan Klasse, Kaustuv Banerjee, et al.
Cancer Drug Resistance (Alhambra, Calif.)|September 30, 2022
A nano-enhanced vaccine for metastatic melanoma immunotherapyKatelyn E Salotto, Walter C Olson, Karlyn E Pollack, et al.
Pageof 105

Showing results (851-860 of 1,043) with videos related to

Sort By:
Pageof 105
Plos One|March 26, 2013
Leucine and protein metabolism in obese Zucker ratsPengxiang She, Kristine C Olson, Yoshihiro Kadota, et al.
Urologic Oncology|October 9, 2025
An opportunity to save? SBRT is less costly than IMRT for intermediate-risk prostate cancerVanessa N Peña, Shan Wu, Oluwaseun Orikogbo, et al.
BMC Medical Research Methodology|March 15, 2020
Incorporating sampling weights into robust estimation of Cox proportional hazards regression model, with illustration in the Multi-Ethnic Study of AtherosclerosisColleen M Sitlani, Thomas Lumley, Barbara McKnight, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 1994
Human biodistribution and dosimetry of the SPECT benzodiazepine receptor radioligand iodine-123-iomazenilH M Dey, J P Seibyl, J B Stubbs, et al.
Journal for Immunotherapy of Cancer|March 14, 2024
Cancer-oocyte SAS1B protein is expressed at the cell surface of multiple solid tumors and targeted with antibody-drug conjugatesArabinda Mandal, Jagathpala Shetty, Christine A Tran, et al.
The Journal of Experimental Medicine|April 28, 2023
Secretory MPP3 reinforce myeloid differentiation trajectory and amplify myeloid cell productionYoon-A Kang, Hyojung Paik, Si Yi Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2004
Administration of CI-1033, an irreversible pan-erbB tyrosine kinase inhibitor, is feasible on a 7-day on, 7-day off schedule: a phase I pharmacokinetic and food effect studyEmiliano Calvo, Anthony W Tolcher, Lisa A Hammond, et al.
Journal of Virology|June 16, 2005
Virus isolates during acute and chronic human immunodeficiency virus type 1 infection show distinct patterns of sensitivity to entry inhibitorsPeter Rusert, Herbert Kuster, Beda Joos, et al.
Plos Pathogens|November 7, 2007
HIV-1 gp120 mannoses induce immunosuppressive responses from dendritic cellsMeimei Shan, Per Johan Klasse, Kaustuv Banerjee, et al.
Cancer Drug Resistance (Alhambra, Calif.)|September 30, 2022
A nano-enhanced vaccine for metastatic melanoma immunotherapyKatelyn E Salotto, Walter C Olson, Karlyn E Pollack, et al.
Pageof 105